scholarly article | Q13442814 |
P50 | author | Michael C. Phillips | Q41206886 |
P2093 | author name string | Hui Li | |
Daniel J Rader | |||
Padmaja Dhanasekaran | |||
Sissel Lund-Katz | |||
Eric T Alexander | |||
P2860 | cites work | The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins | Q24297456 |
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions | Q27672294 | ||
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms | Q27730887 | ||
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site | Q28264429 | ||
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
Apo E structure determines VLDL clearance and atherosclerosis risk in mice. | Q30322098 | ||
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. | Q33769359 | ||
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. | Q34331138 | ||
Apolipoprotein E: From lipid transport to neurobiology | Q34497951 | ||
High density lipoprotein structure-function and role in reverse cholesterol transport | Q35547011 | ||
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. | Q35689481 | ||
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro | Q35991748 | ||
ApoE gene therapy to treat hyperlipidemia and atherosclerosis | Q36586704 | ||
Apolipoprotein E: structure-function relationships | Q40737965 | ||
Gene therapy for atherosclerosis | Q41465066 | ||
Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I. | Q41571954 | ||
Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein | Q41709963 | ||
Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice | Q41952869 | ||
Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4. | Q42005396 | ||
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall | Q42019558 | ||
Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. | Q42173611 | ||
Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms | Q42173744 | ||
Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner | Q42252844 | ||
Molecular mechanism of apolipoprotein E binding to lipoprotein particles | Q42589582 | ||
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. | Q43138847 | ||
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice | Q43916892 | ||
Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. | Q44189963 | ||
Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8. | Q45415785 | ||
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain | Q46175909 | ||
Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia | Q46345830 | ||
Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. | Q46740358 | ||
Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. | Q51580953 | ||
Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice | Q64380964 | ||
Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 687-693 | |
P577 | publication date | 2013-02-14 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels | |
P478 | volume | 33 |
Q33789429 | APOE gene polymorphism in long-lived individuals from a central China population |
Q36843340 | ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis |
Q28249988 | Apolipoprotein E isoforms and lipoprotein metabolism |
Q26747482 | Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders |
Q41036900 | Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction |
Q47270627 | Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E. |
Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
Q36185793 | Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins |
Q89962902 | Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial |
Q36836880 | Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II. |
Q42174067 | Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4. |
Q34614842 | HDL and cognition in neurodegenerative disorders. |
Q42323951 | Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry. |
Q33933106 | Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism |
Q58783963 | In the Heart of the Amazon: Noncommunicable Diseases and Apolipoprotein E4 Genotype in the Riverine Population |
Q88585720 | Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia |
Q33807188 | Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E. |
Q45874364 | The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute |
Search more.